Advertisement

Picture Twist Bioscience We Do DNA 650x100px
Document › Details

Roche. (5/21/18). "Press Release: Roche’s Hemlibra Reduced Treated Bleeds by 96 Percent Compared to No Prophylaxis in Phase III HAVEN 3 Study in Haemophilia A without Factor VIII Inhibitors". Basel.

Region Region Glasgow
  Country United Kingdom (GB)
Organisation Organisation Roche (Group)
Products Product Hemlibra®
  Product 2 clinical research
     


   
Record changed: 2023-06-05

Advertisement

Picture Twist Bioscience We Do DNA 650x200px 1size

More documents for Roche (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Twist Bioscience We Do DNA 650x300px 1size




» top